LEXICON PHARMACEUTICALS, INC. 8-K

What Happened

• Lexicon Pharmaceuticals (LXRX) filed a Form 8-K on May 7, 2026 to announce its financial results for the quarter ended March 31, 2026. The company issued a press release with the results, which is attached to the 8-K as Exhibit 99.1.

Key Details

• Filing date: May 7, 2026.
• Reporting period: quarter ended March 31, 2026.
• Press release attached as Exhibit 99.1 to the Form 8-K.
• Form 8-K was signed by Brian T. Crum, Senior Vice President and General Counsel.
• The filing states the press release and exhibit are furnished, not “filed,” and therefore are not subject to Section 18 liability or automatically incorporated by reference into other SEC filings.

Why It Matters

• This 8-K signals that Lexicon has released its latest quarterly earnings and related financial information; investors should review the attached press release for revenue, earnings, cash position, and any operational updates. Because the materials are furnished (not “filed”), they’re provided for timely investor information but carry different legal treatment under the securities laws.